Riken Vitamin Co., Ltd. (TYO:4526)

Riken Vitamin Statistics

Total Valuation

Riken Vitamin has a market cap or net worth of JPY 90.68 billion. The enterprise value is 81.22 billion.

Market Cap	90.68B
Enterprise Value	81.22B

Important Dates

The last earnings date was Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	Mar 30, 2026

Share Statistics

Riken Vitamin has 29.30 million shares outstanding. The number of shares has decreased by -3.36% in one year.

Current Share Class	29.30M
Shares Outstanding	29.30M
Shares Change (YoY)	-3.36%
Shares Change (QoQ)	-0.70%
Owned by Insiders (%)	11.28%
Owned by Institutions (%)	27.53%
Float	21.44M

Valuation Ratios

The trailing PE ratio is 9.68 and the forward PE ratio is 11.03.

PE Ratio	9.68
Forward PE	11.03
PS Ratio	0.95
PB Ratio	1.11
P/TBV Ratio	1.12
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	8.55
EV / Sales	0.85
EV / EBITDA	8.12
EV / EBIT	11.78
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.21, with a Debt / Equity ratio of 0.10.

Current Ratio	3.21
Quick Ratio	2.07
Debt / Equity	0.10
Debt / EBITDA	0.82
Debt / FCF	n/a
Interest Coverage	58.94

Financial Efficiency

Return on equity (ROE) is 11.73% and return on invested capital (ROIC) is 6.93%.

Return on Equity (ROE)	11.73%
Return on Assets (ROA)	3.69%
Return on Invested Capital (ROIC)	6.93%
Return on Capital Employed (ROCE)	7.21%
Weighted Average Cost of Capital (WACC)	3.72%
Revenue Per Employee	51.26M
Profits Per Employee	5.11M
Employee Count	1,858
Asset Turnover	0.82
Inventory Turnover	3.13

Taxes

In the past 12 months, Riken Vitamin has paid 3.60 billion in taxes.

Income Tax	3.60B
Effective Tax Rate	27.44%

Stock Price Statistics

The stock price has increased by +32.55% in the last 52 weeks. The beta is -0.05, so Riken Vitamin's price volatility has been lower than the market average.

Beta (5Y)	-0.05
52-Week Price Change	+32.55%
50-Day Moving Average	3,023.40
200-Day Moving Average	2,839.42
Relative Strength Index (RSI)	47.89
Average Volume (20 Days)	55,940

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Riken Vitamin had revenue of JPY 95.23 billion and earned 9.50 billion in profits. Earnings per share was 319.59.

Revenue	95.23B
Gross Profit	29.78B
Operating Income	6.90B
Pretax Income	13.10B
Net Income	9.50B
EBITDA	10.01B
EBIT	6.90B
Earnings Per Share (EPS)	319.59

Balance Sheet

The company has 17.68 billion in cash and 8.18 billion in debt, with a net cash position of 9.49 billion or 324.01 per share.

Cash & Cash Equivalents	17.68B
Total Debt	8.18B
Net Cash	9.49B
Net Cash Per Share	324.01
Equity (Book Value)	81.97B
Book Value Per Share	2,790.64
Working Capital	46.50B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 31.27%, with operating and profit margins of 7.24% and 9.98%.

Gross Margin	31.27%
Operating Margin	7.24%
Pretax Margin	13.76%
Profit Margin	9.98%
EBITDA Margin	10.51%
EBIT Margin	7.24%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 110.00, which amounts to a dividend yield of 3.59%.

Dividend Per Share	110.00
Dividend Yield	3.59%
Dividend Growth (YoY)	17.02%
Years of Dividend Growth	4
Payout Ratio	34.42%
Buyback Yield	3.36%
Shareholder Yield	6.96%
Earnings Yield	10.48%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on March 30, 2020. It was a forward split with a ratio of 2.

Last Split Date	Mar 30, 2020
Split Type	Forward
Split Ratio	2

Scores

Riken Vitamin has an Altman Z-Score of 3.67 and a Piotroski F-Score of 4.

Altman Z-Score	3.67
Piotroski F-Score	4